(Q44746790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Rafael Fonseca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

S. Vincent Rajkumar

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

8

Gertz MA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

7

Lust JA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

4

Lacy MQ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Kumar S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Witzig TE

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Wellik LE

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Kyle RA

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Greipp PR

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

624-627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403285

17 November 2019

exact match

0 references

cites work

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Thalidomide as initial therapy for early-stage myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

New perspectives in clinical oncology from angiogenesis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Angiogenesis-dependent diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Prognostic factors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Endothelial cells in the bone marrow of patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Antimyeloma efficacy of thalidomide in the SCID-hu model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Bone marrow angiogenesis in multiple myeloma: effect of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Expression of VEGF and its receptors by myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

Long-term survival in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

7 January 2021

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

7 January 2021

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

7 January 2021

Increased vascularization in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

7 January 2021

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403285

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14749707%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference